{"id":"https://openalex.org/W260665449","doi":"https://doi.org/10.1023/a:1013034615464","title":"Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.","display_name":"Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W260665449","doi":"https://doi.org/10.1023/a:1013034615464","mag":"260665449","pmid":"https://pubmed.ncbi.nlm.nih.gov/11758766"},"language":"en","primary_location":{"id":"doi:10.1023/a:1013034615464","doi":"https://doi.org/10.1023/a:1013034615464","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1013034615464","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045294560","display_name":"Kaneto Uekama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kaneto Uekama","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Kumamoto University, Japan. uekama@gpo.kumamoto-u.ac.jp","Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University, Japan. uekama@gpo.kumamoto-u.ac.jp","institution_ids":["https://openalex.org/I96036126"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000189960","display_name":"Yukako Hieda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukako Hieda","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Kumamoto, 862-0973, Japan","Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Kumamoto, 862-0973, Japan","institution_ids":["https://openalex.org/I96036126"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110110874","display_name":"Fumitoshi Hirayama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumitoshi Hirayama","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Kumamoto, 862-0973, Japan","Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Kumamoto, 862-0973, Japan","institution_ids":["https://openalex.org/I96036126"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103253615","display_name":"Hidetoshi Arima","orcid":"https://orcid.org/0000-0001-5498-4234","observed_orcids":["https://orcid.org/0000-0001-5498-4234"]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidetoshi Arima","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Kumamoto, 862-0973, Japan","Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oehonmachi, Kumamoto, 862-0973, Japan","institution_ids":["https://openalex.org/I96036126"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Kumamoto University,Kumamoto Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masao Sudoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masao Sudoh","raw_affiliation_strings":["Ono Pharmaceutical Co., Minase Research Institute, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","Ono Pharmaceutical Co., Minase Research Institute, Shimamoto-cho, Mishima-gun, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Minase Research Institute, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","institution_ids":["https://openalex.org/I4210112155"]},{"raw_affiliation_string":"Ono Pharmaceutical Co., Minase Research Institute, Shimamoto-cho, Mishima-gun, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108195273","display_name":"Akira Yagi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akira Yagi","raw_affiliation_strings":["Ono Pharmaceutical Co., Minase Research Institute, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","Ono Pharmaceutical Co., Minase Research Institute, Shimamoto-cho, Mishima-gun, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Minase Research Institute, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","institution_ids":["https://openalex.org/I4210112155"]},{"raw_affiliation_string":"Ono Pharmaceutical Co., Minase Research Institute, Shimamoto-cho, Mishima-gun, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"last","author":{"id":null,"display_name":"Hiroshi Terashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Terashima","raw_affiliation_strings":["Ono Pharmaceutical Co., Minase Research Institute, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","Ono Pharmaceutical Co., Minase Research Institute, Shimamoto-cho, Mishima-gun, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ono Pharmaceutical Co., Minase Research Institute, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan","institution_ids":["https://openalex.org/I4210112155"]},{"raw_affiliation_string":"Ono Pharmaceutical Co., Minase Research Institute, Shimamoto-cho, Mishima-gun, Osaka, Japan","institution_ids":["https://openalex.org/I4210112155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045294560"],"corresponding_institution_ids":["https://openalex.org/I96036126"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":1.7139,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.77498918,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"18","issue":"11","first_page":"1578","last_page":"1585"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10721","display_name":"Surfactants and Colloidal Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulfobutylether-beta-cyclodextrin","display_name":"sulfobutylether-\u03b2-cyclodextrin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prostaglandin-e1-analog","display_name":"prostaglandin E1 analogue","score":0.9279999732971191},{"id":"https://openalex.org/keywords/drug-stabilization","display_name":"drug stabilization","score":0.7110000252723694},{"id":"https://openalex.org/keywords/solubilization","display_name":"solubilization","score":0.9079999923706055},{"id":"https://openalex.org/keywords/inclusion-complexes","display_name":"inclusion complexes","score":0.8769999742507935},{"id":"https://openalex.org/keywords/acid-catalyzed-degradation","display_name":"acid-catalyzed degradation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cyclodextrin-derivatives","display_name":"cyclodextrin derivatives","score":0.8489999771118164},{"id":"https://openalex.org/keywords/injectable-formulation","display_name":"injectable formulation","score":0.6079999804496765},{"id":"https://openalex.org/keywords/hemolytic-activity","display_name":"hemolytic activity","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-degradation","display_name":"drug degradation","score":0.3269999921321869}],"concepts":[{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.672595739364624},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.6223633885383606},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5772393941879272},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5485936403274536},{"id":"https://openalex.org/C2779526769","wikidata":"https://www.wikidata.org/wiki/Q4859319","display_name":"Prostaglandin analogue","level":3,"score":0.5340292453765869},{"id":"https://openalex.org/C2780407432","wikidata":"https://www.wikidata.org/wiki/Q103230","display_name":"Ether","level":2,"score":0.49733808636665344},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.4108857810497284},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3923948109149933},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31014710664749146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2950704097747803},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1949971318244934},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.10705834627151489},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000527","descriptor_name":"Alprostadil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000527","descriptor_name":"Alprostadil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002942","descriptor_name":"Circular Dichroism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006868","descriptor_name":"Hydrolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013056","descriptor_name":"Spectrophotometry, Ultraviolet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1023/a:1013034615464","doi":"https://doi.org/10.1023/a:1013034615464","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1013034615464","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:11758766","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11758766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1528165242","https://openalex.org/W1601180248","https://openalex.org/W1608460191","https://openalex.org/W1986518055","https://openalex.org/W1988944787","https://openalex.org/W1990151749","https://openalex.org/W1993072907","https://openalex.org/W1996481160","https://openalex.org/W2009369270","https://openalex.org/W2028775246","https://openalex.org/W2039120138","https://openalex.org/W2045516308","https://openalex.org/W2046017608","https://openalex.org/W2055091943","https://openalex.org/W2057531633","https://openalex.org/W2069763053","https://openalex.org/W2087526401","https://openalex.org/W2089092547","https://openalex.org/W2095357464","https://openalex.org/W2154014672","https://openalex.org/W2164894801","https://openalex.org/W2283449839","https://openalex.org/W2287952311","https://openalex.org/W2312894960","https://openalex.org/W2322726487","https://openalex.org/W2331026709","https://openalex.org/W2419574138","https://openalex.org/W4210979093","https://openalex.org/W4240681501"],"related_works":["https://openalex.org/W2322065250","https://openalex.org/W2331026709","https://openalex.org/W2126196039","https://openalex.org/W2078754183","https://openalex.org/W2368570801","https://openalex.org/W2318338961","https://openalex.org/W2095064333","https://openalex.org/W2057262473","https://openalex.org/W2331404315","https://openalex.org/W2419574138"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}